[Quinolones in the environment: biological breakdown of gyrase inhibitors].
Wetzstein
H G
HG
Bayer AG, Animal Health, Gebäude 6700, 51368 Leverkusen. heinz-georg.wetzstein.hw@bayer-ag.de
D000818:Animals; D000890:Anti-Infective Agents / Q000378:metabolism*; D001673:Biodegradation, Environmental; D004787:Environmental Pollution; D004791:Enzyme Inhibitors / Q000378:metabolism*; D005658:Fungi / Q000378:metabolism; D006801:Humans; D010944:Plants / Q000378:metabolism; D015363:Quinolones / Q000378:metabolism*; D059005:Topoisomerase II Inhibitors
D000890:Anti-Infective Agents; D004791:Enzyme Inhibitors; D015363:Quinolones; D059005:Topoisomerase II Inhibitors